遗传祖先、种族与拉丁美洲急性失代偿期肝硬化严重程度的关联
这项前瞻性队列研究纳入7个拉丁美洲国家44家医院非择期入院的1274例急性失代偿期肝硬化患者,分析遗传祖先和种族与入组时慢加急性肝衰竭(ACLF)的关联。结果显示395例(31.0%)在入组时有任意级别ACLF;校正社会人口学和临床特征后,美洲原住民遗传祖先比例较高与美洲原住民种族均与入组时ACLF独立相关。
要点
- 1274例急性失代偿期肝硬化患者中,395例(31.0%)在入组时有任意级别ACLF。
- ACLF患者美洲原住民遗传祖先中位比例22.6%,无ACLF患者为12.9%。
- 校正混杂因素后,美洲原住民遗传祖先的ACLF比值比为1.08(95% CI,1.03-1.13)。
核心结论
- 在拉丁美洲急性失代偿期肝硬化患者大型队列中,美洲原住民遗传祖先比例升高和美洲原住民种族是与入组时ACLF独立相关的因素。
研究设计与样本
- 前瞻性队列研究,纳入7个拉丁美洲国家44家医院非择期入院的1274例急性失代偿期肝硬化患者,分析遗传祖先和种族等数据。
主要发现
- 395例(31.0%)患者在入组时有任意级别ACLF。
- ACLF患者美洲原住民遗传祖先中位比例为22.6%,无ACLF患者为12.9%;ACLF患者欧洲遗传祖先中位比例为53.4%,无ACLF患者为59.6%。
- ACLF患者和无ACLF患者的非洲遗传祖先中位比例均低。
- ACLF患者中美洲原住民种族比例高于无ACLF患者,欧洲裔美国人或非洲裔美国人比例低于无ACLF患者。
关键数值与推荐
- 校正社会人口学和临床特征差异的多变量分析中,美洲原住民遗传祖先与入组时ACLF的比值比为1.08(95% CI,1.03-1.13)。
- 校正社会人口学和临床特征差异的多变量分析中,美洲原住民种族对比欧洲裔美国人种族的入组时ACLF比值比为2.57(95% CI,1.84-3.58)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Genetic ancestry or racial differences in health outcomes exist in diseases associated with systemic inflammation (eg, COVID-19). This study aimed to investigate the association of genetic ancestry and race with acute-on-chronic liver failure (ACLF), which is characterized by acute systemic inflammation, multi-organ failure, and high risk of short-term death. METHODS: This prospective cohort study analyzed a comprehensive set of data, including genetic ancestry and race among several others, in 1274 patients with acutely decompensated cirrhosis who were nonelectively admitted to 44 hospitals from 7 Latin American countries. RESULTS: Three hundred ninety-five patients (31.0%) had ACLF of any grade at enrollment. Patients with ACLF had a higher median percentage of Native American genetic ancestry and lower median percentage of European ancestry than patients without ACLF (22.6% vs 12.9% and 53.4% vs 59.6%, respectively). The median percentage of African genetic ancestry was low among patients with ACLF and among those without ACLF. In terms of race, a higher percentage of patients with ACLF than patients without ACLF were Native American and a lower percentage of patients with ACLF than patients without ACLF were European American or African American. In multivariable analyses that adjusted for differences in sociodemographic and clinical characteristics, the odds ratio for ACLF at enrollment was 1.08 (95% CI, 1.03-1.13) with Native American genetic ancestry and 2.57 (95% CI, 1.84-3.58) for Native American race vs European American race CONCLUSIONS: In a large cohort of Latin American patients with acutely decompensated cirrhosis, increasing percentages of Native American ancestry and Native American race were factors independently associated with ACLF at enrollment.
引用
- Farias AQ, Curto Vilalta A, Momoyo Zitelli P, et al. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America. Gastroenterology. 2023. PMID: 37263305. doi:10.1053/j.gastro.2023.05.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。